This page shows Forbion European Acquisition Corp (engnw) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 4 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Financial Health Signals
Forbion European Acquisition Corp passes 1 of 9 financial strength tests. 1 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution).
For every $1 of reported earnings, Forbion European Acquisition Corp generates $0.85 in operating cash flow (-$99.2M OCF vs -$117.3M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.
Forbion European Acquisition Corp earns $-41.1 in operating income for every $1 of interest expense (-$123.2M vs $3.0M). This narrow margin raises concern about the company's ability to service its debt if operating income declines.
Key Financial Metrics
Forbion European Acquisition Corp's EBITDA was -$122.7M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 97.9% from the prior year.
Forbion European Acquisition Corp generated -$100.7M in free cash flow in fiscal year 2025, representing cash available after capex. This represents a decrease of 104.7% from the prior year.
Forbion European Acquisition Corp reported -$117.3M in net income in fiscal year 2025. This represents a decrease of 112.7% from the prior year.
Forbion European Acquisition Corp earned $2.29 per diluted share (EPS) in fiscal year 2025. This represents an increase of 56.8% from the prior year.
Forbion European Acquisition Corp held $50.2M in cash against $0 in long-term debt as of fiscal year 2025.
Forbion European Acquisition Corp paid $0.00 per share in dividends in fiscal year 2025.
Forbion European Acquisition Corp had 67M shares outstanding in fiscal year 2025. This represents an increase of 31.4% from the prior year.
Forbion European Acquisition Corp invested $94.5M in research and development in fiscal year 2025. This represents an increase of 146.6% from the prior year.
Forbion European Acquisition Corp invested $1.5M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 60.5% from the prior year.
engnw Income Statement
| Metric | Q3'25 | Q3'25 | Q3'25 | Q3'25 | Q3'24 | Q3'24 | Q3'24 | Q3'24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cost of Revenue | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| R&D Expenses | N/A | $22.6M+11.7% | $20.2M+1.2% | $20.0M | N/A | $11.5M+17.2% | $9.9M+74.8% | $5.6M |
| SG&A Expenses | N/A | $7.4M+6.6% | $6.9M+4.2% | $6.6M | N/A | $5.2M-30.1% | $7.5M+45.2% | $5.1M |
| Operating Income | N/A | -$29.9M-10.4% | -$27.1M-1.9% | -$26.6M | N/A | -$16.8M+3.2% | -$17.3M-60.7% | -$10.8M |
| Interest Expense | N/A | $758K+3.3% | $734K-2.4% | $752K | N/A | $751K+3.2% | $728K+29.3% | $563K |
| Income Tax | N/A | $239K-0.4% | $240K+1233.3% | $18K | N/A | -$29K-238.1% | $21K+170.0% | -$30K |
| Net Income | N/A | -$29.0M-12.3% | -$25.8M-4.9% | -$24.6M | N/A | -$14.1M+5.6% | -$15.0M-39.9% | -$10.7M |
| EPS (Diluted) | N/A | $0.57+11.8% | $0.51+6.3% | $0.48 | N/A | $0.32-15.8% | $0.38-17.4% | $0.46 |
engnw Balance Sheet
| Metric | Q3'25 | Q3'25 | Q3'25 | Q3'25 | Q3'24 | Q3'24 | Q3'24 | Q3'24 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $221.5M-9.8% | $245.6M-7.9% | $266.7M-6.7% | $285.9M-8.1% | $311.2M+16.6% | $266.9M-2.4% | $273.5M+192.8% | $93.4M |
| Current Assets | $201.4M-4.7% | $211.3M-7.3% | $228.0M+2.5% | $222.3M-10.1% | $247.4M-5.8% | $262.7M-2.6% | $269.6M+201.0% | $89.6M |
| Cash & Equivalents | $50.2M+53.7% | $32.6M-43.3% | $57.5M-7.7% | $62.3M-64.0% | $173.0M-32.9% | $257.7M-2.7% | $264.8M+209.2% | $85.6M |
| Inventory | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Accounts Receivable | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Goodwill | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Liabilities | $53.8M+19.8% | $44.9M+14.0% | $39.4M+9.4% | $36.0M-6.7% | $38.6M+5.5% | $36.5M+19.6% | $30.6M-1.5% | $31.0M |
| Current Liabilities | $32.0M+56.5% | $20.4M+13.5% | $18.0M+39.0% | $13.0M-11.6% | $14.7M+8.9% | $13.5M+113.7% | $6.3M-8.8% | $6.9M |
| Long-Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Equity | $167.7M-16.4% | $200.7M-11.7% | $227.3M-9.1% | $249.9M-8.3% | $272.6M+18.4% | $230.3M-5.2% | $243.0M+289.5% | $62.4M |
| Retained Earnings | -$372.0M-11.3% | -$334.2M-9.5% | -$305.2M-9.2% | -$279.3M-9.7% | -$254.7M-6.4% | -$239.4M-6.3% | -$225.3M-7.1% | -$210.3M |
engnw Cash Flow Statement
| Metric | Q3'25 | Q3'25 | Q3'25 | Q3'25 | Q3'24 | Q3'24 | Q3'24 | Q3'24 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$25.0M+2.6% | -$25.6M-11.7% | -$22.9M+10.7% | -$25.7M-31.3% | -$19.6M-172.5% | -$7.2M+49.3% | -$14.2M-92.2% | -$7.4M |
| Capital Expenditures | $437K-37.9% | $704K+1464.4% | $45K-84.9% | $299K+25.6% | $238K+11800.0% | $2K-98.9% | $179K-64.6% | $506K |
| Free Cash Flow | -$25.4M+3.6% | -$26.3M-14.6% | -$23.0M+11.6% | -$26.0M-31.2% | -$19.8M-175.7% | -$7.2M+49.9% | -$14.3M-82.1% | -$7.9M |
| Investing Cash Flow | $40.5M+2836.9% | $1.4M-92.3% | $17.9M+121.1% | -$85.0M+32.2% | -$125.3M-6263200.0% | -$2K+98.9% | -$179K+64.6% | -$506K |
| Financing Cash Flow | $2.0M+398.5% | -$667K-435.2% | $199K+19800.0% | $1K-100.0% | $60.2M+117860.8% | $51K-100.0% | $193.5M+1512.5% | $12.0M |
| Dividends Paid | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
engnw Financial Ratios
| Metric | Q3'25 | Q3'25 | Q3'25 | Q3'25 | Q3'24 | Q3'24 | Q3'24 | Q3'24 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Equity | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Assets | N/A | -11.8%-2.1pp | -9.7%-1.1pp | -8.6% | N/A | -5.3%+0.2pp | -5.5%+6.0pp | -11.5% |
| Current Ratio | 6.30-4.0 | 10.34-2.3 | 12.66-4.5 | 17.16+0.3 | 16.87-2.6 | 19.52-23.3 | 42.80+29.8 | 12.97 |
| Debt-to-Equity | 0.32+0.1 | 0.22+0.1 | 0.17+0.0 | 0.140.0 | 0.14-0.0 | 0.16+0.0 | 0.13-0.4 | 0.50 |
| FCF Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Similar Companies
Frequently Asked Questions
Is Forbion European Acquisition Corp profitable?
No, Forbion European Acquisition Corp (engnw) reported a net income of -$117.3M in fiscal year 2025.
What is Forbion European Acquisition Corp's earnings per share (EPS)?
Forbion European Acquisition Corp (engnw) reported diluted earnings per share of $2.29 for fiscal year 2025. This represents a 56.8% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.
What is Forbion European Acquisition Corp's EBITDA?
Forbion European Acquisition Corp (engnw) had EBITDA of -$122.7M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
What is Forbion European Acquisition Corp's free cash flow?
Forbion European Acquisition Corp (engnw) generated -$100.7M in free cash flow during fiscal year 2025. This represents a -104.7% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Forbion European Acquisition Corp's operating cash flow?
Forbion European Acquisition Corp (engnw) generated -$99.2M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Forbion European Acquisition Corp's total assets?
Forbion European Acquisition Corp (engnw) had $221.5M in total assets as of fiscal year 2025, including both current and long-term assets.
What are Forbion European Acquisition Corp's capital expenditures?
Forbion European Acquisition Corp (engnw) invested $1.5M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
How much does Forbion European Acquisition Corp spend on research and development?
Forbion European Acquisition Corp (engnw) invested $94.5M in research and development during fiscal year 2025.
How many shares does Forbion European Acquisition Corp have outstanding?
Forbion European Acquisition Corp (engnw) had 67M shares outstanding as of fiscal year 2025.
What is Forbion European Acquisition Corp's current ratio?
Forbion European Acquisition Corp (engnw) had a current ratio of 6.30 as of fiscal year 2025, which is generally considered healthy.
What is Forbion European Acquisition Corp's debt-to-equity ratio?
Forbion European Acquisition Corp (engnw) had a debt-to-equity ratio of 0.32 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Forbion European Acquisition Corp's return on assets (ROA)?
Forbion European Acquisition Corp (engnw) had a return on assets of -53.0% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Forbion European Acquisition Corp's cash runway?
Based on fiscal year 2025 data, Forbion European Acquisition Corp (engnw) had $50.2M in cash against an annual operating cash burn of $99.2M. This gives an estimated cash runway of approximately 6 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.
What is Forbion European Acquisition Corp's Piotroski F-Score?
Forbion European Acquisition Corp (engnw) has a Piotroski F-Score of 1 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Forbion European Acquisition Corp's earnings high quality?
Forbion European Acquisition Corp (engnw) has an earnings quality ratio of 0.85x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Forbion European Acquisition Corp cover its interest payments?
Forbion European Acquisition Corp (engnw) has an interest coverage ratio of -41.1x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.